Celixir
Crafting regenerative medicines to enhance patients' lives through pioneering treatments for heart disease and tissue injuries.
Cardiff, United Kingdom
6 employees
Venture round
Total: $2.62M
Biotechnology, Health Care
General Information
Cardiff, United Kingdom
BounceWatch is an independent company data service, not affiliated with Celixir. To contact Celixir, visit celixir.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does Celixir compare?
A PDF of Celixir and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting Celixir soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
Discover More
United Kingdom Market
Biotechnology
About Celixir
Business keywords: Regenerative Medicine, Medical Research, Cell Therapy, Heart Disease, Tissue Injury, Medical Innovation, iMP Cells, Platelet Lysate, PML Cells, Ischaemic Heart Disease, Tendon Injury, Heart Failure, Medical Care, Patient Treatment
Funding Rounds & Investors (3)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Venture Round | $1.50M | 1 |
|
21 Mar 2018 |
| Venture Round | $1.08M | - |
|
01 Dec 2014 |
| Seed Round | $40.00K | - |
|
01 Mar 2013 |
Celixir Alternatives & Competitors
View All Alternatives
Striving to transform the treatment of disease by harnessing the power of cell therapy
Clinical-stage biotech company developing iPSC-derived highly purified ventricular cardiomyocytes fo...
FAQ About Celixir
Source: BounceWatch company record for Celixir, https://bouncewatch.com/company/celixir, updated 10 October 2024. When citing, please name BounceWatch and link this page.
